Accent Microcell Limited (NSE:ACCENTMIC)
525.00
+11.55 (2.25%)
Jul 13, 2026, 3:29 PM IST
Accent Microcell Revenue
In the fiscal year ending March 31, 2026, Accent Microcell had annual revenue of 3.50B INR with 32.03% growth. Accent Microcell had revenue of 2.10B in the half year ending March 31, 2026, with 54.30% growth.
Revenue
3.50B
Revenue Growth
+32.03%
P/S Ratio
3.60
Revenue / Employee
13.45M
Employees
260
Market Cap
12.58B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.50B | 848.35M | 32.03% |
| Mar 31, 2025 | 2.65B | 192.53M | 7.84% |
| Mar 31, 2024 | 2.46B | 483.37M | 24.50% |
| Mar 31, 2023 | 1.97B | 315.51M | 19.04% |
| Mar 31, 2022 | 1.66B | 322.98M | 24.21% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Remus Pharmaceuticals | 8.54B |
| Infinium Pharmachem | 1.90B |
| Zenith Drugs | 1.71B |
| Quest Laboratories | 1.26B |
| Sotac Pharmaceuticals | 1.02B |
| Sunrest Lifescience | 708.33M |
| Vilin Bio Med | 422.63M |
| Medicamen Organics | 226.30M |